Mission To ensure that our therapies have their greatest impact by always focusing on the patient, and following the science to run impactful and high-quality clinical development. Pipeline Linsitinib is an oral therapy being developed for thyroid eye disease (TED) that will ease the treatment burden for patients, caregivers, and physicians. Leadership We have an […]
